Histological study on pN upgrading of oral cancer

被引:77
作者
Hamakawa, H [1 ]
Takemura, K
Sumida, T
Kayahara, H
Tanioka, H
Sogawa, K
机构
[1] Ehime Univ, Dept Oral & Maxillofacial Surg, Sch Med, Shigenobu, Ehime 7910295, Japan
[2] Univ Tokushima, Sch Med, Dept Surg 1, Tokushima 7708503, Japan
来源
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY | 2000年 / 437卷 / 02期
关键词
oral cancer; pN upgrading; immunohistochemistry; micrometastasis; semiserial sectioning;
D O I
10.1007/s004280000199
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The International Union Against Cancer (UICC) does not define the number of sections required from each regional lymph node to record pTNM classification. This study was designed to clarify the incidence of occult metastasis and to assess the pN upgrading of patients with oral cancer. Ultimately, this study led to a proposal for appropriate semiserial sectioning guidelines. Five hundred fifty-four nonmetastatic cervical lymph nodes taken from 73 patients with oral cancer were subjected to hematoxylin-eosin (HE) staining and keratin immunohistochemistry. Micrometastases, defined as foci less than or equal to 3 mm, were detected in 29 sites of 23 lymph nodes (4.2%) of 16 patients (21.9%). In 9 patients (12.3%) pN upgrading was needed: in 6 from pN0 to pN1, in 1 from pN0 to pN2b, and in 2 from pN1 to pN2b. The remaining 13 lymph nodes with occult metastasis were found in 5 pN2b and 2 pN2c patients, resulting in no pN upgrading. Occult metastasis was also detected in 6 small lymph nodes less than or equal to 5 mm in diameter. The average minor axis of the micrometastasis was 1.36+/-0.85 mm. We propose that the lymph nodes should be cut and examined at l-mm intervals to detect micrometastatic foci and to evaluate the pN classification accurately.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 39 条
  • [1] Ambrosch P, 1996, Oncology (Williston Park), V10, P1221
  • [2] Bertoglio S, 1997, J Chemother, V9, P119
  • [3] Czerniecki BJ, 1999, CANCER, V85, P1098, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1098::AID-CNCR13>3.3.CO
  • [4] 2-E
  • [5] DAVIDSON BR, 1990, CANCER-AM CANCER SOC, V65, P967, DOI 10.1002/1097-0142(19900215)65:4<967::AID-CNCR2820650424>3.0.CO
  • [6] 2-Y
  • [7] DEGUCHI T, 1993, CANCER RES, V53, P5350
  • [8] Glickman JN, 1999, CANCER, V85, P769, DOI 10.1002/(SICI)1097-0142(19990215)85:4<769::AID-CNCR3>3.0.CO
  • [9] 2-I
  • [10] GREENSON JK, 1994, CANCER-AM CANCER SOC, V73, P563, DOI 10.1002/1097-0142(19940201)73:3<563::AID-CNCR2820730311>3.0.CO